approved EB-2 (NIW)

Scientist

Biomedical Science · China · 2025-01-30

Processing Time
69 days
Decision Date
2025-01-30
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop state-of-the-art gene testing technologies to identify genetic markers associated with a wide range of human diseases. This work aims to facilitate early disease diagnoses and enable the development of effective treatments and personalized medicine approaches.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research supports U.S. healthcare outcomes and biomedical innovation through advanced genetic testing methods.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of highly cited publications and peer review experience demonstrates authority and innovation in the field.

3 Balance of Interests/Waiver Benefit Met

It was demonstrated that waiving the job offer requirement is in the best interest of the United States to drive progress in precision medicine.

Why This Petition Was Approved

The case was approved based on the petitioner's record of 5 peer-reviewed journal articles, 4 abstracts, and 526 citations, demonstrating wide influence in the field. Additionally, the petitioner completed 41 peer reviews for leading journals, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
Texas 30 days 2025-06-20
The petitioner proposes to elucidate the molecular mechanisms connecting genetic variation to complex disease outcomes using RNA sequencing, whole genome sequencing, and proteomics. This work aims to support the advancement of precision medicine through the development of accurate diagnostics and tailored therapies for various disorders.

Postdoctoral Researcher

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
California 249 days 2025-05-28
The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
163 days 2024-11-28
The petitioner proposes to utilize advanced computational genetics and multi-omics data analysis tools to elucidate the mechanisms underlying complex diseases and phenotypes. Her work focuses on uncovering biological processes to improve early diagnosis and treatment of these conditions.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Illinois 36 days 2025-09-05
The petitioner proposes to develop cutting-edge genomic technologies to understand the functions of non-coding RNAs. This research aims to uncover their roles in human disease and repurpose them as programmable tools for biotechnology and therapeutic applications.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 69 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist